How is sesamin metabolised in the human liver to show its biological effects?

被引:20
作者
Yasuda, Kaori [1 ]
Sakaki, Toshiyuki [1 ]
机构
[1] Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Imizu, Toyama 9390398, Japan
关键词
cytochrome P450; metabolism; sesamin; UDP-glucuronosyltransferase; MECHANISM-BASED INACTIVATION; METHYLENEDIOXYPHENYL COMPOUNDS; RAT-LIVER; CARDIOVASCULAR HYPERTROPHY; CYTOCHROME-P450; 3A4; FUNCTIONAL LIGNAN; COMPLEX-FORMATION; GAMMA-TOCOPHEROL; DNA MICROARRAY; INHIBITION;
D O I
10.1517/17425255.2012.637917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Sesamin is a major lignan found in sesame and is known to have various biological effects. Some of these biological effects occur following its metabolic conversion to corresponding catechols and, therefore, the study of sesamin metabolism is quite important. There is currently a need to identify the enzymes responsible for metabolism of sesamin so that scientists will be more able to predict sesamin-drug interactions. Areas Covered: The authors reviewed all the published literature with a focus on papers that dealt with metabolism of sesamin by drug-metabolising enzymes in rat and/or human liver, such as cytochrome P450 and UDP-glucuronosyltransferase. The article also reviews papers that dealt with the inhibition of enzymes by sesamin including drug-metabolising enzymes and other physiologically important enzymes. Additionally, the authors discuss the species-based differences in the metabolism of sesamin between rats and humans. Expert opinion: A remarkable species-based difference was found in sesamin metabolism between humans and other animals; thus, it is very important that precautions are taken when predicting the physiological effects in humans from animal data. A mechanism-based inhibition of human CYP2C9 by sesamin was recently discovered, suggesting that it is important to evaluate the interaction between sesamin and drugs that are mainly metabolised by CYP2C9. Furthermore, further analysis of sesamin and episesamin and their molecular mechanisms are needed to make better use of sesamin supplements.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 52 条
[21]   Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats [J].
Liu, Z ;
Saarinen, NM ;
Thompson, LU .
JOURNAL OF NUTRITION, 2006, 136 (04) :906-912
[22]  
Matsumura Y, 1998, BIOL PHARM BULL, V21, P469, DOI 10.1248/bpb.21.469
[23]  
MATSUMURA Y, 1995, BIOL PHARM BULL, V18, P1016, DOI 10.1248/bpb.18.1016
[24]  
Miyahara Y, 2000, INT J MOL MED, V6, P43
[25]   Antioxidative catechol lignans converted from sesamin and sesaminol triglucoside by culturing with Aspergillus [J].
Miyake, Y ;
Fukumoto, S ;
Okada, M ;
Sakaida, K ;
Nakamura, Y ;
Osawa, T .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (01) :22-27
[26]   Antihypertensive Effects of Sesamin in Humans [J].
Miyawaki, Takashi ;
Aono, Hideshi ;
Toyoda-Ono, Yoshiko ;
Maeda, Hirofumi ;
Kiso, Yoshinobu ;
Moriyama, Kenji .
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2009, 55 (01) :87-91
[27]   Quantitative NMR analysis of a sesamin catechol metabolite in human urine [J].
Moazzami, Ali A. ;
Andersson, Rolf E. ;
Kamal-Eldin, Afaf .
JOURNAL OF NUTRITION, 2007, 137 (04) :940-944
[28]  
Moritani T., 2003, Medicine & Science in Sports & Exercise, V35, pS269, DOI 10.1097/00005768-200305001-01490
[29]   Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation [J].
Murray, M .
CURRENT DRUG METABOLISM, 2000, 1 (01) :67-84
[30]   Novel antioxidative metabolites in rat liver with ingested sesamin [J].
Nakai, M ;
Harada, M ;
Nakahara, K ;
Akimoto, K ;
Shibata, H ;
Miki, W ;
Kiso, Y .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2003, 51 (06) :1666-1670